Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis

Author：

Publisher： Spandidos Publications

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.33, Iss.3, 2014-01, pp. : 711-721

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis

By Ohsugi Yoshiyuki Kishimoto Tadamitsu

Expert Opinion on Biological Therapy, Vol. 8, Iss. 5, 2008-05 ,pp. : 669-681

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacology and Therapeutic Potential of Monoclonal Antibody Treatment in Rheumatoid Arthritis

By Choy E.H.S.

Drugs & Aging, Vol. 12, Iss. 2, 1998-02 ,pp. : 139-148

Adis International

Access to resources Recommend Favorite

In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma

By Nestor M. Persson M. Dongen G. Jensen H. Lundqvist H. Anniko M. Tolmachev V.

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 32, Iss. 11, 2005-11 ,pp. : 1296-1304

Springer Publishing Company

Access to resources Recommend Favorite

Treatment with a Chimeric CD4 Monoclonal Antibody is Associated with a Relative Loss of CD4 + /CD45RA + Cells in Patients with Rheumatoid Arthritis

By van der Lubbe P.A. Breedveld F.C. Tak P.P. Schantz A. Woody J. Miltenburg A.M.M.

Journal of Autoimmunity, Vol. 10, Iss. 1, 1997-01 ,pp. : 87-97

Academic Press

Access to resources Recommend Favorite

Effects of Anti-IL-5 Monoclonal Antibody on the Murine Model of Nasal Allergy

International Archives of Allergy and Immunology, Vol. 116, Iss. 1, 2009-07 ,pp. : 49-52

Karger

Access to resources Recommend Favorite